Double-blind randomised trial comparing the non-steroidal aromatase inhibitors letrozole and fadrozole in postmenopausal women with advanced breast cancer

Superior Efficacy of Letrozole Versus Tamoxifen as First-Line Therapy for Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Study of the International Letrozole Breast Cancer Group

Henning T. Mouridsen, Mikhail Gershanovich, Yan Sun et al. · Journal of Clinical Oncology · 2001 · 1K citations · Full text

Medicine, Oncology, Pharmacology +17

Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate.

P Dombernowsky, I E Smith, Geoffrey Falkson et al. · Journal of Clinical Oncology · 1998 · 640 citations

Medicine, Oncology, Pharmacology +16

Influence of Letrozole and Anastrozole on Total Body Aromatization and Plasma Estrogen Levels in Postmenopausal Breast Cancer Patients Evaluated in a Randomized, Cross-Over Study

Jürgen Geisler, Ben P. Haynes, Gun Anker et al. · Journal of Clinical Oncology · 2002 · 575 citations

Medicine, Oncology, Pharmacology +17

The general rules for clinical and pathological recording of breast cancer

Surgery Today · 1989 · 377 citations

Medicine, Oncology, Pathology +16

Phase III, Multicenter, Double-Blind, Randomized Study of Letrozole, an Aromatase Inhibitor, for Advanced Breast Cancer Versus Megestrol Acetate

Aman U. Buzdar, Joeri A J Douma, Nancy E. Davidson et al. · Journal of Clinical Oncology · 2001 · 364 citations

Medicine, Pharmacology, Pharmacotherapy +17